Standring David 4
4 · IDENIX PHARMACEUTICALS INC · Filed Feb 18, 2009
Insider Transaction Report
Form 4
Standring David
EVP, Biology
Transactions
- Award
Employee Stock Option (Right to Buy)
2009-02-13+45,000→ 45,000 totalExercise: $5.46Exp: 2019-02-12→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]This option vests in 48 equal monthly installments beginning on February 28, 2009.